Rural Health
News by Topic: Legislation and regulations
CMS: Medicare Program; FY 2026 Inpatient Psychiatric Facilities Prospective Payment System-Rate Update
Federal Register
Aug 5, 2025 - Notice of a final rule from the Centers for Medicare & Medicaid Services (CMS) updating the FY 2026 prospective payment rates, outlier threshold, and wage index for Medicare inpatient hospital services provided by inpatient psychiatric facilities (IPF), including psychiatric hospitals and excluded psychiatric units of an acute care hospital or Critical Access Hospital. Includes a revision to the payment adjustment factors for teaching status and for IPFs in rural areas. These changes will be effective for IPF discharges occurring during the fiscal year beginning October 1, 2025, through September 30, 2026. This final rule also includes changes to measures used in the Inpatient Psychiatric Facilities Quality Reporting (IPFQR) Program and changes to update and codify the Extraordinary Circumstances Exception policy. These changes are effective October 1, 2025.
Source: Federal Register
Aug 5, 2025 - Notice of a final rule from the Centers for Medicare & Medicaid Services (CMS) seeking comments on updates to the prospective payment system for inpatient rehabilitation facilities (IRFs) for fiscal year 2026. Among other things, this rule proposes classification and weighting factors for the IRF prospective payment system's case-mix groups, continues the second year of the 3-year phase-out of the rural adjustments, and includes proposals for the IRF Quality Reporting Program. This final rule is effective October 1, 2025.
Source: Federal Register
Aug 4, 2025 - Notice of final rule from the Centers revising the hospital inpatient prospective payment system (IPPS) for operating and capital-related costs of acute care hospitals for fiscal year 2026. This rule also makes changes related to Medicare graduate medical education (GME) for teaching hospitals; updates payment policies and the annual payment rates for the Medicare prospective payment system (PPS) for inpatient hospital services provided by long-term care hospitals; updates and make changes to requirements for certain quality programs; and finalizes certain updates to the ONC Health Information Technology (IT) Certification Program among other things. These final rules are effective October 1, 2025.
Source: Federal Register
Aug 4, 2025 - Notice of final rule from the Centers for Medicare & Medicaid Services (CMS) updating the skilled nursing facility (SNF) prospective payment system (PPS) payment rates for fiscal year 2026. Among other things, this rule updates the requirements for the SNF Quality Reporting Program and the SNF Value-Based Purchasing Program. These regulations are effective October 1, 2025.
Source: Federal Register
CMS: Agency Information Collection Activities: Submission for OMB Review; Comment Request; Correction
Federal Register
Aug 1, 2025 - Notice from the Centers for Medicare & Medicaid Services making a point of contact correction to the June 20, 2025 information collection.
Source: Federal Register
CMS: Agency Information Collection Activities: Proposed Collection; Comment Request
Federal Register
Jul 31, 2025 - Notice from the Centers for Medicare & Medicaid Services seeking comments on the following information collections: 1) Medicare Quality of Care Complaint Form; 2) Solicitation for Applications for Medicare Prescription Drug Plan 2027 Contracts; and 3) Annual Notice of Change and Evidence of Coverage for Applicable Integrated Plans in States that Require Integrated Materials. Comments are due by September 29, 2025.
Source: Federal Register
FDA: Revocation of Emergency Use of a Drug Product During the COVID-19 Pandemic; Availability
Federal Register
Jul 29, 2025 - The Food and Drug Administration (FDA) has revoked Emergency Use Authorizations issued to Regeneron Pharmaceuticals, Inc., for REGEN-COV (casirivimab and imdevimab administered together); GlaxoSmithKline LLC for sotrovimab; Eli Lilly and Company for bebtelovimab; and AstraZeneca Pharmaceuticals LP for EVUSHELD (tixagevimab co-packaged with cilgavimab). These revocations are effective December 13, 2024.
Source: Federal Register
DOD: TRICARE Coverage of Clinical Trials and Termination of Expanded Access Treatments
Federal Register
Jul 28, 2025 - Notice of final rule from the Department of Defense (DOD) Defense Health Agency (DHA) finalizing provisions published in two interim final rules (IFRs) that temporarily added coverage for the treatment use of investigational drugs under U.S. Food and Drug Administration (FDA)-authorized expanded access (EA) programs when for the treatment of coronavirus disease 2019 (COVID-19) and permitted coverage of National Institute of Allergy and Infectious Disease (NIAID)-sponsored clinical trials for the treatment or prevention of COVID-19. Among other things, this rule discusses the DOD's decision not to make permanent the coverage of treatment use of investigational drugs under FDA EA programs while updating language for care associated with their administration and broadens the COVID-19 clinical trial benefit to include coverage of clinical trials sponsored or approved by any National Institutes of Health (NIH) Center or Institute to treat or prevent infectious diseases associated with a pandemic or epidemic. This rule is effective August 27, 2025.
Source: Federal Register
Jul 25, 2025 - Highlights the Rural Health Transformation Program, part of
the One Big Beautiful Bill Act.
Source: The White House
Jul 23, 2025 - Announcement from the Centers for Medicare & Medicaid Services (CMS) of receipt of an application for continued recognition of the Accreditation Commission for Health Care as a national accrediting organization for Critical Access Hospitals that wish to participate in the Medicare or Medicaid programs. Comments are due by August 22, 2025.
Source: Federal Register